Coherus BioSciences Inc. (CHRS) Leaped After Patent Victory

Coherus BioSciences Inc. (CHRS) announced Tuesday that the Patent Trial and Appeal Board ruled in its favor in a case against AbbVie (ABBV) over U.S. Patent 8,889,135.

from RTT - Before the Bell http://ift.tt/2rulEiP
via IFTTT